Comparison of 6- with 9-week trials of adjunctive imipramine in postpsychotic depression

Samuel G. Siris, Federico Adan, Alene Strahan, Andrew Aronson, John Mandeli, Bernadette Fasano-Dube

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Outcome at 6 weeks versus outcome at 9 weeks was compared in 23 patients with syndromally defined episodes of postpsychotic depression who underwent a trial of adjunctive imipramine added to their continuing treatment with fluphenazine decanoate and benztropine. The global outcome after 9 weeks was found to be superior. The implications of this finding for the treatment of secondary depressions in patients with schizophrenia and schizoaffective disorder is discussed.

Original languageEnglish (US)
Pages (from-to)483-488
Number of pages6
JournalComprehensive Psychiatry
Volume30
Issue number6
DOIs
StatePublished - Jan 1 1989

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Comparison of 6- with 9-week trials of adjunctive imipramine in postpsychotic depression'. Together they form a unique fingerprint.

  • Cite this

    Siris, S. G., Adan, F., Strahan, A., Aronson, A., Mandeli, J., & Fasano-Dube, B. (1989). Comparison of 6- with 9-week trials of adjunctive imipramine in postpsychotic depression. Comprehensive Psychiatry, 30(6), 483-488. https://doi.org/10.1016/0010-440X(89)90077-1